Skip to main content
logo
Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China flag China · Delayed Price · Currency is CNY
15.51
-0.51 (-3.18%)
Mar 30, 2026, 3:00 PM CST

SHA:688488 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-141.2-76.07-124.09-29.99
Depreciation & Amortization
52.7345.137.8530.21
Other Amortization
3.972.653.512.44
Loss (Gain) From Sale of Assets
--0.07-0.03-1.58
Asset Writedown & Restructuring Costs
65.6323.80.31-
Loss (Gain) From Sale of Investments
-17.73-14.16-14.14-8.09
Provision & Write-off of Bad Debts
-3.343.728.87-2.49
Other Operating Activities
18.4811.7736.2110.89
Change in Accounts Receivable
76.98-82.92-66.6631.35
Change in Inventory
-44.28-52.4-74.62-36.7
Change in Accounts Payable
-14.34-8.84118.873.87
Change in Other Net Operating Assets
-5.31-2.8--
Operating Cash Flow
-37.5-166.22-92.55-12.37
Capital Expenditures
-44.56-71.2-140.3-94.78
Sale of Property, Plant & Equipment
0.121.320.680.01
Investment in Securities
125.35135.88-274.75311.12
Other Investing Activities
4.197.448.6414.17
Investing Cash Flow
85.173.44-405.72230.53
Long-Term Debt Issued
410.87395.29205-
Total Debt Issued
410.87395.29205-
Long-Term Debt Repaid
-340.15-198.33-5.5-2.76
Total Debt Repaid
-340.15-198.33-5.5-2.76
Net Debt Issued (Repaid)
70.72196.96199.5-2.76
Issuance of Common Stock
-5.48--
Common Dividends Paid
-15.85-11.66-3.47-20.16
Financing Cash Flow
54.86190.78196.03-22.92
Foreign Exchange Rate Adjustments
-0.0100.47-0.15
Net Cash Flow
102.4698-301.77195.08
Free Cash Flow
-82.06-237.43-232.85-107.15
Free Cash Flow Margin
-19.64%-57.72%-95.34%-41.90%
Free Cash Flow Per Share
-0.20-0.56-0.56-0.25
Cash Income Tax Paid
22.8722.29-6.6711.66
Levered Free Cash Flow
-9.98-247.7-196.07-81.12
Unlevered Free Cash Flow
-0.38-240.35-193.62-80.97
Change in Working Capital
-16.04-162.97-41.05-13.77
Source: S&P Global Market Intelligence. Standard template. Financial Sources.